Dr. Marat Fudim and Dr. C. Michael Gibson discuss: Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial August 31, 2026 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson discuss: Effect on Oxidized Phospholipids of Lepodisiran, an Extended Duration siRNA Targeting Lipoprotein(a) August 31, 2026 Disclosures: TBD
Dr. Michael Vinther and Dr. C. Michael Gibson discuss: HIS Alternative II August 31, 2026 Disclosures: TBD
Dr. Niraj Varma and Dr. C. Michael Gibson discuss: SyncAV PMT: Clinical Benefit of Dynamic AV Optimization in CRT August 31, 2026 Disclosures: TBD
Dr. Jens Cosedis Nielsen and Dr. C. Michael Gibson discuss: DANISH-CRT: Targeted LV lead placement for biventricular pacing for heart failure August 31, 2026 Disclosures: TBD
Dr. Maoyi Tian and Dr. C. Michael Gibson discuss: ECLIPSE-CKD: Salt Substitute in Chronic Kidney Disease August 30, 2026 Disclosures: TBD
Dr. Kazem Rahimi and Dr. C. Michael Gibson discuss: Blood Pressure-Lowering Treatment Across the Spectrum of Cardiovascular Risk August 30, 2026 Disclosures: TBD
Dr. Rolf Wachter and Dr. C. Michael Gibson discuss: PVI-SHAM-AF: Pulmonary Vein Isolation versus SHAM in AF August 30, 2026 Disclosures: TBD
Dr. Joerg Hausleiter and Dr. C. Michael Gibson discuss: TRIC-I-HF: Tricuspid Intervention in Heart Failure August 30, 2026 Disclosures: TBD
Dr. James Januzzi and Dr. C. Michael Gibson discuss: LUMINARA: a prospective RCT of a once daily oral relaxin agonist for treating heart failure August 30, 2026 Disclosures: TBD
